Maravai LifeSciences Statistics
Share Statistics
Maravai LifeSciences has 143.97M
shares outstanding. The number of shares has increased by 8.15%
in one year.
| Shares Outstanding | 143.97M |
| Shares Change (YoY) | 8.15% |
| Shares Change (QoQ) | 1.27% |
| Owned by Institutions (%) | 99.14% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 7,708 |
| FTD / Avg. Volume | 0.29% |
Short Selling Information
The latest short interest is 14.6M, so 10.14% of the outstanding
shares have been sold short.
| Short Interest | 14.6M |
| Short % of Shares Out | 10.14% |
| Short % of Float | 12.06% |
| Short Ratio (days to cover) | 7.42 |
Valuation Ratios
The PE ratio is -5.19 and the forward
PE ratio is -9.27.
Maravai LifeSciences's PEG ratio is
-0.31.
| PE Ratio | -5.19 |
| Forward PE | -9.27 |
| PS Ratio | 2.9 |
| Forward PS | 1.3 |
| PB Ratio | 2.31 |
| P/FCF Ratio | -33.87 |
| PEG Ratio | -0.31 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Maravai LifeSciences.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.53,
with a Debt / Equity ratio of 1.16.
| Current Ratio | 7.53 |
| Quick Ratio | 6.65 |
| Debt / Equity | 1.16 |
| Debt / EBITDA | -2.4 |
| Debt / FCF | -16.97 |
| Interest Coverage | -4.94 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $454,710.53 |
| Profits Per Employee | $-254,115.79 |
| Employee Count | 570 |
| Asset Turnover | 0.26 |
| Inventory Turnover | 3.01 |
Taxes
| Income Tax | -1.86M |
| Effective Tax Rate | 0.71% |
Stock Price Statistics
The stock price has increased by -74.37% in the
last 52 weeks. The beta is 0.25, so Maravai LifeSciences's
price volatility has been higher than the market average.
| Beta | 0.25 |
| 52-Week Price Change | -74.37% |
| 50-Day Moving Average | 2.08 |
| 200-Day Moving Average | 5.1 |
| Relative Strength Index (RSI) | 51.98 |
| Average Volume (20 Days) | 2,685,520 |
Income Statement
In the last 12 months, Maravai LifeSciences had revenue of 259.19M
and earned -144.85M
in profits. Earnings per share was -1.05.
| Revenue | 259.19M |
| Gross Profit | 108.31M |
| Operating Income | -235.62M |
| Net Income | -144.85M |
| EBITDA | -156.92M |
| EBIT | -213.78M |
| Earnings Per Share (EPS) | -1.05 |
Full Income StatementBalance Sheet
The company has 322.4M in cash and 376.69M in
debt, giving a net cash position of -54.29M.
| Cash & Cash Equivalents | 322.4M |
| Total Debt | 376.69M |
| Net Cash | -54.29M |
| Retained Earnings | 140.89M |
| Total Assets | 959.75M |
| Working Capital | 313.12M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 7.46M
and capital expenditures -29.66M, giving a free cash flow of -22.19M.
| Operating Cash Flow | 7.46M |
| Capital Expenditures | -29.66M |
| Free Cash Flow | -22.19M |
| FCF Per Share | -0.16 |
Full Cash Flow StatementMargins
Gross margin is 41.79%, with operating and profit margins of -90.91% and -55.89%.
| Gross Margin | 41.79% |
| Operating Margin | -90.91% |
| Pretax Margin | -100.89% |
| Profit Margin | -55.89% |
| EBITDA Margin | -60.54% |
| EBIT Margin | -90.91% |
| FCF Margin | -8.56% |
